Dr. David Gasalberti

Radiation OncologyMale7+ years of experience
Dr. David Gasalberti is a radiation oncologist in Middletown, Connecticut. He graduated from Drexel University College of Medicine in 2015 and has been in practice for 7+ years.
LocationEducationRatingsAbout MeHospitalsConditions TreatedSpecialtySimilar

Location

Dr. David Gasalberti
536 Saybrook Road
Middletown, Connecticut 06457

Education

Medical school

Dr. Gasalberti attended Drexel University College of Medicine and graduated in 2015 (7 years ago). Drexel University College of Medicine is ranked #85 number in the "Best Medical Schools" by U.S. News.

About Me

Dr. Gasalberti works at Central Connecticut Radiation Oncology PC, which has 5 other health providers.

Primary specialty
Radiation Oncology
Years of experience
7+ years
Gender
Male
NPI
1639565948

Hospital Affiliations

Dr. Gasalberti is affiliated with the following hospitals.

Middlesex Hospital

Conditions Treated

As a radiation oncology, Dr. Gasalberti may see patients with the following conditions. Please check with Dr. Gasalberti what conditions he treats. Dr. Gasalberti may treat additional conditions not listed.

  • Acoustic neuroma
  • Acute lymphocytic leukemia
  • Adnexal tumors
  • Adrenal cancer
  • Ameloblastoma
  • Ampullary cancer
  • Anal cancer
  • Bladder cancer
  • Bone cancer
  • Brain cancer
Show more +

Specialties

Dr. Gasalberti is a radiation oncologist.

Radiation Oncology

A radiation oncologist is a specialist physician who uses ionizing radiation (such as megavoltage X-rays or radionuclides) in the treatment of cancer. Radiation oncology is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. Radiation can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers. A radiation oncologist may also use radiation to treat some benign diseases, including benign tumors.